Adipose Stromal Cell Contact with Endothelial Cells Results in Loss of Complementary Vasculogenic Activity Mediated by Induction of Activin A

Adipose stem/stromal cells (ASCs) after isolation produce numerous angiogenic growth factors. This justifies their use to promote angiogenesis per transplantation. In parallel, local coimplantation of ASC with endothelial cells (ECs) leading to formation of functional vessels by the donor cells suggests the existence of a mechanism responsible for fine‐tuning ASC paracrine activity essential for vasculogenesis. As expected, conditioned media (CM) from ASC promoted ECs survival, proliferation, migration, and vasculogenesis. In contrast, media from EC‐ASC cocultures had neutral effects upon EC responses. Media from cocultures exhibited lower levels of vascular endothelial growth factor (VEGF), hepatic growth factor, angiopoietin‐1, and stromal cell‐derived factor‐1 compared with those in ASC CM. Activin A was induced in ASC in response to EC exposure and was responsible for overall antivasculogenic activity of EC‐ASC CM. Except for VEGF, activin A diminished secretion of all tested factors by ASC. Activin A mediated induction of VEGF expression in ASC, but also upregulated expression of VEGF scavenger receptor FLT‐1 in EC in EC‐ASC cocultures. Blocking the FLT‐1 expression in EC led to an increase in VEGF concentration in CM. In vitro pre‐exposure of ASC to low number of EC before subcutaneous coimplantation with EC resulted in decrease in vessel density in the implants. In vitro tests suggested that activin A was partially responsible for this diminished ASC activity. This study shows that neovessel formation is associated with induction of activin A expression in ASC; this factor, by affecting the bioactivity of both ASC and EC, directs the crosstalk between these complementary cell types to establish stable vessels. Stem Cells 2015;33:3039–3051

[1]  W. Holnthoner,et al.  Adipose‐derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix , 2015, Journal of tissue engineering and regenerative medicine.

[2]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[3]  K. March,et al.  Adipose Stromal Cells Differentiate Along a Smooth Muscle Lineage Pathway Upon Endothelial Cell Contact via Induction of Activin A , 2014, Circulation research.

[4]  A. Bura,et al.  Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. , 2014, Cytotherapy.

[5]  A. Das,et al.  A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia , 2013, Journal of Translational Medicine.

[6]  J. Cha,et al.  Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. , 2013, The international journal of biochemistry & cell biology.

[7]  M. Corselli,et al.  Perivascular cells for regenerative medicine , 2012, Journal of cellular and molecular medicine.

[8]  D. Nam,et al.  Therapeutic effects of human adipose stem cell‐conditioned medium on stroke , 2012, Journal of neuroscience research.

[9]  S. Hsiao,et al.  Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. , 2012, Stem cells and development.

[10]  Byung-Soo Kim,et al.  Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. , 2012, Tissue engineering. Part A.

[11]  M. Sefton,et al.  Cotransplantation of adipose-derived mesenchymal stromal cells and endothelial cells in a modular construct drives vascularization in SCID/bg mice. , 2012, Tissue engineering. Part A.

[12]  S. Miettinen,et al.  Adipose Stromal Cell Tubule Network Model Provides a Versatile Tool for Vascular Research and Tissue Engineering , 2012, Cells Tissues Organs.

[13]  T. Hong,et al.  Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[14]  Elizabeth A. Logsdon,et al.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions. , 2012, Tissue engineering. Part A.

[15]  W. Pu,et al.  Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells , 2012, Angiogenesis.

[16]  K. Pramanik,et al.  Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and Factors , 2012, American journal of reproductive immunology.

[17]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[18]  K. Matsumoto,et al.  Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer , 2011, British Journal of Cancer.

[19]  B. Kalionis,et al.  Immunosuppressive Properties of Mesenchymal Stem Cells , 2011, Stem Cell Reviews and Reports.

[20]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[21]  M. Goumans,et al.  Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. , 2011, Stem cell research.

[22]  Keith L March,et al.  Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation. , 2010, Tissue engineering. Part A.

[23]  M. Hoogduijn,et al.  Embryonic Stem Cell Marker Expression Pattern in Human Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, Heart and Dermis , 2009, Stem Cell Reviews and Reports.

[24]  B. Tomanek,et al.  Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. , 2009, American journal of physiology. Heart and circulatory physiology.

[25]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[26]  R. Gutiérrez,et al.  Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. , 2009, Histology and histopathology.

[27]  M. Murphy,et al.  Robust Functional Vascular Network Formation In Vivo by Cooperation of Adipose Progenitor and Endothelial Cells , 2009, Circulation research.

[28]  V. Tkachuk,et al.  Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. , 2009, Tissue engineering. Part A.

[29]  H. Hampel,et al.  IFATS Collection: The Conditioned Media of Adipose Stromal Cells Protect Against Hypoxia‐Ischemia‐Induced Brain Damage in Neonatal Rats , 2009, Stem cells.

[30]  M. Fishbein,et al.  IFATS Collection: Human Adipose Tissue‐Derived Stem Cells Induce Angiogenesis and Nerve Sprouting Following Myocardial Infarction, in Conjunction with Potent Preservation of Cardiac Function , 2009, Stem cells.

[31]  T. Murohara,et al.  Implantation of Adipose-Derived Regenerative Cells Enhances Ischemia-Induced Angiogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Lei Yuan,et al.  Engineering Robust and Functional Vascular Networks In Vivo With Human Adult and Cord Blood–Derived Progenitor Cells , 2008, Circulation research.

[33]  M. Zago,et al.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. , 2008, Experimental hematology.

[34]  F. Prósper,et al.  Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction , 2008, European journal of heart failure.

[35]  W. Arap,et al.  A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks , 2008, Circulation research.

[36]  J. Jung,et al.  Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. , 2007, International journal of cardiology.

[37]  Kenneth Cornetta,et al.  Suppression of Hepatocyte Growth Factor Production Impairs the Ability of Adipose‐Derived Stem Cells to Promote Ischemic Tissue Revascularization , 2007, Stem cells.

[38]  J. Gimble,et al.  Cytokine profile of human adipose‐derived stem cells: Expression of angiogenic, hematopoietic, and pro‐inflammatory factors , 2007, Journal of cellular physiology.

[39]  Florian Tögel,et al.  Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. , 2007, American journal of physiology. Renal physiology.

[40]  M. Shibuya Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis , 2006, Angiogenesis.

[41]  Guodong Pan,et al.  Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  K. Kangawa,et al.  Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. , 2005, Cardiovascular research.

[44]  K. Yoshiura,et al.  A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells. , 2004, Biochemical and biophysical research communications.

[45]  S. Kishi,et al.  Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor. , 2004, Endocrinology.

[46]  R Busse,et al.  Improvement of Postnatal Neovascularization by Human Adipose Tissue–Derived Stem Cells , 2004, Circulation.

[47]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[48]  D. Endo,et al.  Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. , 2004, Journal of hepatology.

[49]  B. Lévy,et al.  Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives , 2004, Circulation.

[50]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[51]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[52]  D. Charnock-Jones,et al.  Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. , 1999, Molecular endocrinology.

[53]  M. Clauss,et al.  Functions of the VEGF receptor-1 (FLT-1) in the vasculature. , 1998, Trends in cardiovascular medicine.

[54]  S. McCarthy,et al.  Inhibition of vascular endothelial cell growth by activin-A. , 1993, The Journal of biological chemistry.

[55]  R. Beygui,et al.  Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. , 2005, Cytotherapy.

[56]  V. V. van Hinsbergh,et al.  Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix , 2004, Angiogenesis.

[57]  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use , 2002 .